Impact of magnesium supplementation on clinical outcome and disease progression of patients with diabetic nephropathy: a prospective randomized trial

被引:1
|
作者
Halawa, Nihal [2 ]
Elsaid, Tamer Wahid [3 ]
El Wakeel, Lamia Mohamed [2 ]
Shawki, May Ahmed [1 ]
机构
[1] Ain Shams Univ, Fac Pharm, Clin Pharm Dept, African Union Org, Cairo 11566, Egypt
[2] Ain Shams Univ, Fac Pharm, Clin Pharm Dept, Cairo, Egypt
[3] Ain Shams Univ, Fac Med, Nephrol Dept, Cairo, Egypt
关键词
diabetic nephropathy; magnesium; microalbuminuria; osteocalcin; oxidative stress; CHRONIC KIDNEY-DISEASE; BONE TURNOVER; DOUBLE-BLIND; BIOCHEMICAL MARKERS; SERUM MAGNESIUM; INSULIN-RESISTANCE; RENAL-FAILURE; MICROALBUMINURIA; HYPOMAGNESEMIA; DENSITY;
D O I
10.1177/20406223231214641
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background:Magnesium (Mg) deficiency is closely linked with proteinuria.Objectives:To assess the impact of oral Mg citrate supplementation on the clinical outcome of diabetic nephropathy (DN) patients.Design:This was a prospective, randomized, controlled, open-label study.Methods:Sixty DN patients were recruited from Nephrology and Endocrinology departments, Ain Shams University Hospitals, Cairo, Egypt. Patients were assigned by stratified randomization based on their Mg status, to either Mg citrate group, (n = 30), who received the standard regimen + oral Mg citrate 2.25 g/day or Control group, (n = 30), who received the standard regimen only. The primary endpoint was a change in urinary albumin to creatinine ratio (UACR) after 12 weeks. Secondary outcomes were insulin resistance, glycemic control, lipid profile, serum osteocalcin, quality of life (QoL) and Mg tolerability.Results:Out of a total of 60 patients enrolled, only 54 patients (26 in Mg citrate group and 28 in the control group) completed the study. Groups were comparable at baseline. The UACR median percent reduction was significantly higher in the Mg citrate group (-6.87%) versus (-0.9%) in the Control group, p = 0.001. After 12 weeks, the estimated glomerular filtration rate significantly improved in the Mg citrate group versus Control group (p = 0.001). Comparable change was observed in glycemic indices. Lipid profile significantly improved in the Mg citrate group versus Control group (p = 0.001). Serum osteocalcin levels significantly declined in the Mg citrate group (p = 0.001) versus control group. Regarding QoL, the total score and all domains significantly improved in the Mg citrate group compared to control. The Mg supplement was tolerable with only mild reported side effects that required no intervention.Conclusion:Oral Mg citrate supplementation improved microalbuminuria in DN patients. It also had favorable effects on serum osteocalcin, lipid profile and QoL with no reported major side effects.Trial registration:ClinicalTrials.gov identifier: NCT03824379.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patients: randomized controlled trial
    El-Kady, Rasha R.
    Ali, Amani K.
    El Wakeel, Lamia M.
    Sabri, Nagwa A.
    Shawki, May A.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2022, 13
  • [22] Timing of magnesium supplementation in patients with nephrolithiasis: A randomized controlled trial
    Sharbaugh, Adam J.
    Ayyash, Omar M.
    Riley, Julie M.
    Averch, Timothy D.
    Semins, Michelle J.
    CLINICAL NEPHROLOGY, 2025,
  • [23] The effect of vitamin D supplementation on the outcome of treatment with bevacizumab in diabetic macular edema: a randomized clinical trial
    Sahba Fekri
    Masoud Soheilian
    Sepehr Roozdar
    Seyed-Hossein Abtahi
    Hosein Nouri
    International Ophthalmology, 2022, 42 : 3345 - 3356
  • [24] The effect of vitamin D supplementation on the outcome of treatment with bevacizumab in diabetic macular edema: a randomized clinical trial
    Fekri, Sahba
    Soheilian, Masoud
    Roozdar, Sepehr
    Abtahi, Seyed-Hossein
    Nouri, Hosein
    INTERNATIONAL OPHTHALMOLOGY, 2022, 42 (11) : 3345 - 3356
  • [25] Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease A Randomized Clinical Trial
    Kieburtz, Karl
    Tilley, Barbara C.
    Elm, Jordan J.
    Babcock, Debra
    Hauser, Robert
    Ross, G. Webster
    Augustine, Alicia H.
    Augustine, Erika U.
    Aminoff, Michael J.
    Bodis-Wollner, Ivan G.
    Boyd, James
    Cambi, Franca
    Chou, Kelvin
    Christine, Chadwick W.
    Cines, Michelle
    Dahodwala, Nabila
    Derwent, Lorelei
    Dewey, Richard B., Jr.
    Hawthorne, Katherine
    Houghton, David J.
    Kamp, Cornelia
    Leehey, Maureen
    Lew, Mark F.
    Liang, Grace S. Lin
    Luo, Sheng T.
    Mari, Zoltan
    Morgan, John C.
    Parashos, Sotirios
    Perez, Adriana
    Petrovitch, Helen
    Rajan, Suja
    Reichwein, Sue
    Roth, Jessie Tatsuno
    Schneider, Jay S.
    Shannon, Kathleen M.
    Simon, David K.
    Simuni, Tanya
    Singer, Carlos
    Sudarsky, Lewis
    Tanner, Caroline M.
    Umeh, Chizoba C.
    Williams, Karen
    Wills, Anne-Marie
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (06): : 584 - 593
  • [26] Dietary magnesium supplementation in cats with chronic kidney disease: A prospective double-blind randomized controlled trial
    Tang, Pak-Kan
    van den Broek, Dirk Hendrik Nicolaas
    Jepson, Rosanne E.
    Geddes, Rebecca F.
    Chang, Yu-Mei
    Loetter, Nicola
    Moniot, Delphine
    Biourge, Vincent
    Elliott, Jonathan
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2024, 38 (04) : 2180 - 2195
  • [27] The prevention of contrast induced nephropathy by sarpogrelate in patients with chronic kidney disease: a study protocol for a prospective randomized controlled clinical trial
    Park, Kyungil
    Chung, Woo-Young
    Seo, Jae-Bin
    Kim, Sang-Hyun
    Zo, Joo-Hee
    Kim, Myung-A
    Park, Young-Bae
    TRIALS, 2010, 11
  • [28] The prevention of contrast induced nephropathy by sarpogrelate in patients with chronic kidney disease: a study protocol for a prospective randomized controlled clinical trial
    Kyungil Park
    Woo-Young Chung
    Jae-Bin Seo
    Sang-Hyun Kim
    Joo-Hee Zo
    Myung-A Kim
    Young-Bae Park
    Trials, 11
  • [29] Impact of restenosis and disease progression on clinic outcome after multivessel stenting in diabetic patients
    Loutif, M
    Salengro, E
    Mulvihill, NT
    Boccalatte, M
    Farah, B
    Laborde, JC
    Fajadet, J
    Marco, J
    CIRCULATION, 2002, 106 (19) : 625 - 626
  • [30] Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy A Randomized Controlled Trial
    House, Andrew A.
    Eliasziw, Misha
    Cattran, Daniel C.
    Churchill, David N.
    Oliver, Matthew J.
    Fine, Adrian
    Dresser, George K.
    Spence, J. David
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (16): : 1603 - 1609